Mechanistic Studies of Nicotinamide Riboside in Human Heart Failure

NCT04528004 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

ACTIVE_NOT_RECRUITING

Status

32

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure, Systolic
Heart Failure NYHA Class IV
Metabolic Disturbance

Interventions

DRUG: Nicotinamide riboside
OTHER: Placebo

Sponsor

University of Washington

Collaborators

[object Object]